Metraipolis › archive › dc_2dd588f7fe0d

Acquired MTAP Loss Following Entrectinib Resistance in ROS1-Rearranged NSCLC With CD74 Exon 3-ROS1 Exon 34 Fusion — Europe PMC PMID:41120096

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41120096
DOI
10.1111/1759-7714.70176
License (as archived)
solo-consultazione
Archived
2026-11-09T16:31:55.862Z
SHA-256 of the archived text
f32666830d6d162d8ff4292ef6266e4a0614fff83dec4978b95b86acb4630953
Stable URL of this page
https://metraipolis.com/documento/dc_2dd588f7fe0d

How to cite

Acquired MTAP Loss Following Entrectinib Resistance in ROS1-Rearranged NSCLC With CD74 Exon 3-ROS1 Exon 34 Fusion — Europe PMC PMID:41120096 — Europe PMC (en), https://europepmc.org/article/MED/41120096 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2dd588f7fe0d (Metraipolis archive dc_2dd588f7fe0d, sha256 f32666830d6d162d8ff4292ef6266e4a0614fff83dec4978b95b86acb4630953)
BibTeX
@misc{dc2dd588f7fe0d,
  title = {Acquired MTAP Loss Following Entrectinib Resistance in ROS1-Rearranged NSCLC With CD74 Exon 3-ROS1 Exon 34 Fusion — Europe PMC PMID:41120096},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41120096},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2dd588f7fe0d; sha256 f32666830d6d162d8ff4292ef6266e4a0614fff83dec4978b95b86acb4630953},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41120096. Agents can read the archived copy with the MCP tool read_document.